Latest News and Press Releases

The acquisition of eight pharmacies at an aggregate purchase price of approximately $24.2 millionThe acquisitions are expected to increase PharmaCorp’s store count from six to fourteen locations,...

Fourth quarter 2025 revenue up 75% compared to the fourth quarter 2024Fourth quarter 2025 gross profit increased 78% compared to the fourth quarter 2025Fourth quarter same-store sales up 6% and...

SASKATOON, Saskatchewan, April 13, 2026 (GLOBE NEWSWIRE) -- PHARMACORP RX INC. (“PharmaCorp” or the “Corporation”) (TSXV: PCRX) is pleased to announce it has entered into a public listing services...

SASKATOON, Saskatchewan, April 02, 2026 (GLOBE NEWSWIRE) -- PharmaCorp Rx Inc. (“PharmaCorp” or the “Corporation”) (TSXV: PCRX) a Canadian pharmacy services and consolidation platform, announced...

SASKATOON, Saskatchewan, March 04, 2026 (GLOBE NEWSWIRE) -- PHARMACORP RX INC. (“PharmaCorp” or the “Corporation”) (TSXV: PCRX) has granted a total of 213,519 options to purchase common ‎shares to...

PHARMACORP ANNOUNCES GRANT OF STOCK OPTIONS

SASKATOON, Saskatchewan, Dec. 11, 2025 (GLOBE NEWSWIRE) -- PHARMACORP RX INC. (“PharmaCorp” or the “Corporation”) (TSXV: PCRX) is pleased to announce that it has entered into a non-binding letter of...

SASKATOON, Saskatchewan, Nov. 28, 2025 (GLOBE NEWSWIRE) -- PHARMACORP RX INC. (“PharmaCorp” or the “Corporation”) (TSXV: PCRX) a growing national platform for pharmacist-led community pharmacy...

SASKATOON, Saskatchewan, Nov. 28, 2025 (GLOBE NEWSWIRE) -- PHARMACORP RX INC. (“PharmaCorp” or the “Corporation”) (TSXV: PCRX) today announced an executive transition in which Paul Dale has been...

PharmaCorp Announces Supplemental Listing of Warrants